A Phase Ⅳ Study of Decitabine in Myelodysplastic Syndrome
NCT02013102
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
240
Enrollment
INDUSTRY
Sponsor class
Conditions
Myelodysplastic Syndrome
Interventions
DRUG:
Decitabine Injection
Sponsor
Cttq